Error loading player: No playable sources found
3565
Epi I: Best of Observational Studies in IBD
Date
May 19, 2024
SOCIETY: AGA This session highlights the best of the best observational studies in IBD for DDW 2024 and provides clinical relevant and novel insights into how quality of care initiatives, viruses, disability, intestinal anastomosis, and the incidence of IBD in Hispanics can help you in your day to day practice.
Moderators
University of Maryland
Massachusetts General Hospital
Tracks
Related Products
IBD Controlled Trials II
SOCIETY: AGA This session is the second session of the ever-popular and clinically impactful clinical trials sessions in IBD. Insights into novel agents including obefazimod, VTX002. MH002, risankizumab, and mirikizumab will be presented…
Uncontrolled Therapeutic Observations in IBD
SOCIETY: AGA In this session, several clinically relevant presentations will put the attendee at the cutting edge of research and clinical care, with regard to stem cells for perinal fistulas, biologic de-escalation, subcutaneous biologics, and use of small molecules in microscopic colitis
Role of the Environment in IBD
SOCIETY: AGA As our scientific tools improve, so does our ability to link the environment with different aspects of IBD…
IBD Adverse Events Related to Therapy: Focus on Small Molecules
SOCIETY: AGA Small molecules are a new exicting therapeutic class in IBD that may have potential safety signals which have not been well described in the real world…
